Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
22
7
2018
medline:
15
5
2019
entrez:
21
7
2018
Statut:
ppublish
Résumé
Identification of patients with cancer predisposition syndromes (CPSs) can provide vital information to guide care of an existing cancer, survey for future malignancy, and counsel families. The same underlying mutation responsible for a CPS may also result in other phenotypic abnormalities amenable to therapeutic intervention. The purpose of this study was to examine patients followed in our multidisciplinary CPS clinic to determine the prevalence and scope of medical and psychosocial needs. Data from a baseline evaluation of a single-center patient registry was reviewed. Eligible patients included those with a known or suspected CPS. Over 3 years, 73 patients consented and had successful follow-up. Utilization rate of special therapies, defined as speech therapy, occupational therapy, and/or physical therapy, in the CPS population was 50.7%, significantly higher than a representative sample of children with special needs. Prevalence of 504/IEP (Individualized Education Program) utilization was 20.5%. Patients with CPSs have a high prevalence of medical and psychosocial needs beyond their risk for cancer, for which early screening for necessary interventions should be offered to maximize the patient's developmental potential. Future research is needed to further define the developmental and cognitive phenotypes of these syndromes, and to evaluate the effectiveness of subsequent interventions.
Identifiants
pubmed: 30028825
doi: 10.1097/MPH.0000000000001251
pmc: PMC6348029
mid: NIHMS976605
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
133-136Subventions
Organisme : NCI NIH HHS
ID : P30 CA091842
Pays : United States
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1295-7
pubmed: 18314872
Br J Cancer. 1991 Jun;63(6):993-9
pubmed: 2069856
Arch Pediatr Adolesc Med. 1999 Mar;153(3):254-60
pubmed: 10086402
J Pediatr. 1988 Feb;112(2):201-9
pubmed: 3339501
Pediatrics. 2005 Dec;116(6):1346-52
pubmed: 16322157
Pediatr Blood Cancer. 2012 Jan;58(1):85-9
pubmed: 21850677
Int J Cancer. 2006 Nov 1;119(9):2001-6
pubmed: 16642469
Dev Psychopathol. 2008 Summer;20(3):775-803
pubmed: 18606031
Am J Hum Genet. 2003 Jan;72(1):156-60
pubmed: 12439823
Med Pediatr Oncol. 2002 Apr;38(4):229-39
pubmed: 11920786
J Clin Oncol. 2005 Jan 10;23(2):276-92
pubmed: 15637391
Lancet Oncol. 2011 Jun;12(6):559-67
pubmed: 21601526